This page was reviewed but not written by the grant investigators. Binx staff also reviewed this page prior to publication.
Open Philanthropy recommended an investment of $2,000,000 in Binx to support work to incorporate Sherlock Biosciences’s COVID-19 assay into Binx’s point-of-care diagnostic platform. This funding is intended to support work to obtain Emergency Use Authorization approval of the Binx-Sherlock Biosciences COVID-19 testing platform.
This falls within our work on scientific research, specifically within our interest in advancing science supporting biosecurity and pandemic preparedness.